Treatment of Fatigue with Rifetech Plasma (Energy Medicine)

Treatment of Fatigue with Rifetech Plasma (Energy Medicine) - Rifetech

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031476

Enrollment

100

Registered

2023-04-04

Start date

2023-04-11

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G93.3

Interventions

Group 1: Treatment with Rifetech: The treatment will be by a Rifetech-Plasma device. This devices generates low-energy electromagnetic frequencies in the range between some hundred and some kilohertz.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: German language proficiency working email address informed consent

Exclusion criteria

Exclusion criteria: Fatigue because of medication or surgery

Design outcomes

Primary

Measure	Time frame
Fatigue Severity Scale German: The outcome will be measured at entry and 4 weeks later.	—

Secondary

Measure	Time frame
Other treatments: Open question as to whether other treatments have been applied.	—

Countries

Germany

Contacts

Public ContactHarald Walach

CHS-Institut

hw@chs-institute.org+49 30 467 97 436

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026